Press release
Attention Deficit Hyperactivity Disorder Therapeutics Market is Projected to Register at a Healthy CAGR of 6.2%
Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/4222
The market is segmented based on drug type, age group, distribution channel, and region. On the basis of drug type, the market has been broadly segmented into stimulants (Amphetamine, Methylphenidate, Dextroamphetamine, Dexmethylphenidate, and Lisdexamfetamine Dimesylate) and non-stimulants (Atomoxetine, Bupropion, Guanfacine, and Clonidine). By drug type, the Lisdexamfetamine Dimesylate drug type sub-segment is expected to register highest CAGR of 15.6% in terms of value over the forecast period. The longer effectiveness of the treatment and easier availability is expected to contribute to its growing adoption. The Lisdexamfetamine Dimesylate drug type sub-segment is expected to reach a market value of US$ 5,682.2 Mn by 2024 end. Stimulants are expected to emerge as the most preferred drug type for both patients and physicians globally over the forecast period. The second-most popular drug type sub-segment is Amphetamine, expected to register a CAGR of 4.2% during the forecast period.
Rising prevalence of ADHD owing to the low threshold of diagnostic criteria, increasing awareness regarding ADHD, and shift from ICD-10 to DSM-IV are major factors driving the growth of the global ADHD therapeutics market currently. Other trends driving market growth are increasing concerns among parents and cultural differences towards ADHD, rising ADHD drug usage in adults, and novel drug development.
Generic drug manufacturers in the global ADHD therapeutics market are focusing on introducing cheaper and effective generic ADHD drugs to increase market share, the post-patent expiry of prescription drugs. Furthermore, adoption of alternative treatment methods and drug abuse are factors hampering the growth of this market.
This report assesses trends driving each market segments and sub-segments and offers analysis and insights into the potential of ADHD therapeutics therapies in specific regions. North America is estimated to dominate the global ADHD therapeutics market, with a maximum value share of the overall market by the end of 2016. By 2024, North America and Europe markets are expected to account for over four-fifths share of the global ADHD therapeutics market revenue. In terms of value, North America is estimated to be the dominant market, registering a CAGR of 5.9% over the forecast period.
Request Report Multiple Chapter @ https://www.persistencemarketresearch.com/multiple-chapter/4222
Some key companies covered in this report include Eli Lilly and Company, Novartis AG, Shire PLC, Pfizer, Inc., GlaxoSmithKline PLC, Mallinckrodt Pharmaceuticals, Hisamitsu Pharmaceutical Co., Inc., Impax Laboratories, Inc., Johnson & Johnson, UCB S.A., and Purdue Parma L.P. These companies are primarily focused on enhancing their product portfolio through research and development and on introduction of innovative and cost-effective treatment procedures in order to gain higher market share and to strengthen their respective positions in the global market.
Get full report now @ https://www.persistencemarketresearch.com/checkout/4222
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Attention Deficit Hyperactivity Disorder Therapeutics Market is Projected to Register at a Healthy CAGR of 6.2% here
News-ID: 1062001 • Views: …
More Releases from Persistence Market Research pvt ltd
Rise of Cloud Computing and Big Data Analytics Drives Processor Market Growth to …
According to a recent report by Persistence Market Research, the global processor market is expected to reach a value of US$ 332.0 billion by 2033, growing at a CAGR of approximately 9.6% during the forecast period.
The increasing demand for processors in smartphones, tablets, and other mobile devices is a key driver of market growth. The report also notes that the demand for processors in the automotive industry is expected…
Building Products Market Expected to Grow at 5.2% CAGR to Reach USD 1.5 Trillion …
the global building products market size was valued at USD 1.1 trillion and is expected to reach USD 1.5 trillion by 2026, growing at a CAGR of 5.2% during the forecast period.
The building products market encompasses a wide range of products used in the construction and renovation of residential, commercial, and industrial buildings. These products include but are not limited to lumber and wood products, roofing materials, insulation, windows and…
Road Sweeping Machine Market Size to Surpass US$ 5.9 billion by 2028 | Persisten …
Road Sweeping Machine Market
The global road sweeping machine market is expected to reach a value of US$ 5.9 billion by 2028, growing at a CAGR of 6.5% from 2023 to 2028. The market growth is driven by several factors such as urbanization, increasing infrastructure development, rising awareness about environmental cleanliness, and government initiatives to promote sustainable living.
Click Here to Get Free Sample Copy of this Report @https://www.persistencemarketresearch.com/samples/16750
Road sweeping machines are…
Pigments & Dyes Market is expected to grow at a CAGR of 4.3% from 2023 to 2028
Pigments & Dyes Market
The global pigments and dyes market was valued at US$ 27.8 billion in 2022 and is expected to grow at a CAGR of 4.3% from 2022 to 2028, according to a report by PMR. The growth in the market can be attributed to the increasing demand for pigments and dyes from end-use industries such as textiles, paints, coatings, and plastics. The demand for high-performance pigments and dyes…
More Releases for ADHD
Artist With ADHD Completes Most Dangerous Painting
While artist Bryan Lewis Saunders (1) has drawn under the influence of various drugs, this illustrator draws while partaking in every day activities - even while driving or walking. Van Jazmin, a 28 year old graphic designer in Los Angeles, began drawing from life as a means to cope with anxiety. “It’s why I started drawing at parties… a fidgeting habit which has since evolved into its own art practice,”…
ADHD Therapeutics Market - Factors Driving Growth Post 2024
Global ADHD Therapeutics Information, by drug types (Stimulants and Non-stimulants), by distribution channels (hospitals, clinics, pharmacies, research laboratories and others) - Forecast to 2024
ADHD is one of the most common neurodevelopmental disorders of childhood. It is usually first diagnosed in childhood and often lasts into adulthood. Children with ADHD may have trouble paying attention, controlling impulsive behaviors or be hyperactive. It is normal for children to have trouble focusing and…
Global ADHD Drugs Market Research Report 2017
Qyresearchreports include new market research report "Global ADHD Drugs Market Research Report 2017" to its huge collection of research reports.
The research report offers a comprehensive analysis of the global ADHD Drugs market, emphasizing on the key factors impacting the growth of the market. The factors affecting the growth of the market have been studied thoroughly and valuation of the market has been provided in the report. This report provides accurate…
ADHD Answers from an ADHD Teen Brings Help to Parents, ADHD Boys
Sept. 4, 2006--Parents of boys with Attention Deficit Disorder (ADHD) have a new place to find answers to questions, problem-solving suggestions, and general help and support, both for their sons and for themselves. But the help comes from a source some will find surprising. \"Talk Back with Jack\" offers a forum for 11-year-old Jack Dixon to offer help and advice to ADHD boys and their parents as part of That\'s…
ADHD Myths — What If There Really Isn’t Anything Wrong with ADHD Children?
February 6, 2006 (Washington, D.C.) - An ADHD diagnosis can often signal a lifetime of struggles for children. But consider the case of Robbie Raffino.
Robbie used to rise every day like most eight-year-olds. He'd wipe the sleepiness from his eyes, throw on shorts and shirt that don't match and eat cereal while watching cartoons.
But the innocence ended there. He'd swallow his Ritalin, hop on the school bus and enter…
Making ADHD Kids Winners
(Washington, D.C.) January 31, 2006 - Parents of children with ADHD, or Attention Deficit Disorder, are no different than other parents-they want their kids to be winners in life. Like all children, kids with ADHD face many unique challenges in life.
So what lessons can ADHD families learn from elite athletes preparing to battle for the Super Bowl Championship?
According to Kirk Martin, Founder of educational organization Celebrate! ADHD, “Children with…
